Ep176: David Roblin on Building a TechBio Company
The Long Run with Luke Timmerman
00:00
Intro
This chapter features the CEO of Relation Therapeutics, who explains how multi-omic tools are revolutionizing drug target identification from human tissues. The discussion emphasizes the value of interdisciplinary collaboration in advancing biopharma research, alongside Relation Therapeutics' partnership with GSK aimed at tackling fibrosis and osteoarthritis.
Transcript
Play full episode
